|
GPRASP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.35770000026159E-07 |
| Normal-vs-Stage3 |
1.37110000020257E-07 |
| Normal-vs-Stage4 |
4.88253881769651E-12 |
| Stage1-vs-Stage2 |
2.556600E-01 |
| Stage1-vs-Stage3 |
2.484600E-01 |
| Stage1-vs-Stage4 |
4.228000E-01 |
| Stage2-vs-Stage3 |
9.188400E-01 |
| Stage2-vs-Stage4 |
1.844570E-01 |
| Stage3-vs-Stage4 |
2.045400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.62481139653892E-12 |
| Normal-vs-Asian |
5.21739999981286E-07 |
| Caucasian-vs-AfricanAmerican |
4.712200E-01 |
| Caucasian-vs-Asian |
7.887200E-01 |
| AfricanAmerican-vs-Asian |
9.963800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.43818290609943E-12 |
| Male-vs-Female |
9.002300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.08482145278322E-14 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
1.62447832963153E-12 |
| Normal-vs-Extreme_Obese |
2.21830331881279E-11 |
| Normal_Weight-vs-Extreme_Weight |
2.254800E-01 |
| Normal_Weight-vs-Obese |
7.365000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.698000E-01 |
| Extreme_Weight-vs-Obese |
6.816400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.067800E-01 |
| Obese-vs-Extreme_Obese |
4.877600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.86399809318527E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.2640999358382E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.419600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.338000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.431200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.797050E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.128000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.214400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
1.62792002100787E-12 |
| Normal-VS-KIRP CIMP |
1.92673999999116E-05 |
| Normal-VS-Unclassified PRCC |
1.29519728275795E-11 |
| Type1 PRCC-VS-Type2 PRCC |
1.558350E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.636300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.616000E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.233970E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.166800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.651550E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.07339999999112E-05 |
| Normal-vs-N2 |
8.38680003223402E-09 |
| N0-vs-N1 |
2.217000E-01 |
| N0-vs-N2 |
2.653400E-01 |
| N1-vs-N2 |
2.581000E-01 |
|
|
